Le Lézard
Classified in: Health
Subject: SVY

South Korea Dental Bone Graft Substitutes and Other Biomaterials Markets, 2024 - Overview, Competitive Analysis, Market Trends & Market Developments


DUBLIN, March 26, 2019 /PRNewswire/ -- The "Dental Bone Graft Substitutes and Other Biomaterials Market - South Korea - 2018-2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The dental biomaterials market is growing at a similar rate to that of dental implants, as the DBGS and other biomaterials market is primarily driven by the growth of the dental implant market and increasing proportion of implant procedures using dental biomaterials.

The total number of procedures that involve biomaterials is growing in proportion to improvements in consumer awareness, as well as the training and education of the dental professionals that place implants. Additionally, as implantology is integrated into the workflow of a general practitioner (GP), the population of dentists willing to invest in pricey equipment, such as growth factors, is expected to expand.

Key Topics Covered:

1 Executive Summary

2 Disease Overview

3 Product Assessment
3.1 Introduction
3.2 Product Portfolios
3.3 Fda Recalls
3.4 Clinical Trials

4 South Korean Dental Bone Graft Substitutes And Other Biomaterials Market Overview
4.1 Introduction
4.2 Currency Exchange Rate
4.3 Market Overview
4.4 Trend Analysis By Segment
4.5 Market Penetration
4.6 Drivers And Limiters
4.6.1 Market Drivers
4.6.2 Market Limiters
4.7 Competitive Market Share Analysis
4.8 Mergers And Acquisitions
4.9 Company Profiles
4.10 Swot Analysis

5 Dental Bone Graft Substitute Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis And Forecast
5.3.1 Total Dental Bone Graft Substitute Market
5.3.2 Allograft Market
5.3.2.1 Mineralized Allograft Market
5.3.2.2 Demineralized Bone Matrix Market
5.3.3 Xenograft Market
5.3.4 Synthetic Market
5.4 Drivers And Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

6 Dental Growth Factor Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis And Forecast
6.3.1 Emdogain Market
6.3.2 Gem 21S Market
6.3.3 Infuse Market
6.3.4 Osteocel Market
6.4 Drivers And Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

7 Dental Barrier Membrane Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis And Forecast
7.3.1 Total Dental Barrier Membrane Market
7.3.2 Resorbable Dental Barrier Membrane Market
7.3.3 Non-Resorbable Dental Barrier Membrane Market
7.4 Market Penetration
7.5 Drivers And Limiters
7.5.1 Market Drivers
7.5.2 Market Limiters
7.6 Competitive Market Share Analysis

8 Abbreviations

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/23l79k/south_korea?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: